229 related articles for article (PubMed ID: 1480040)
1. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
Banda MJ; Howard EW; Herron GS; Apodaca G
Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
[TBL] [Abstract][Full Text] [Related]
2. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
Apodaca G; Rutka JT; Bouhana K; Berens ME; Giblin JR; Rosenblum ML; McKerrow JH; Banda MJ
Cancer Res; 1990 Apr; 50(8):2322-9. PubMed ID: 2156617
[TBL] [Abstract][Full Text] [Related]
3. TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.
Stetler-Stevenson WG; Krutzsch HC; Liotta LA
Matrix Suppl; 1992; 1():299-306. PubMed ID: 1480041
[TBL] [Abstract][Full Text] [Related]
4. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
[TBL] [Abstract][Full Text] [Related]
5. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
7. Cloning and regulation of rat tissue inhibitor of metalloproteinases-2 in osteoblastic cells.
Cook TF; Burke JS; Bergman KD; Quinn CO; Jeffrey JJ; Partridge NC
Arch Biochem Biophys; 1994 Jun; 311(2):313-20. PubMed ID: 8203893
[TBL] [Abstract][Full Text] [Related]
8. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
Moore WG; Birkedal-Hansen B; Pierson M; Birkedal-Hansen H
Matrix Suppl; 1992; 1():319-20. PubMed ID: 1480050
[No Abstract] [Full Text] [Related]
9. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
10. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor.
DeClerck YA; Yean TD; Chan D; Shimada H; Langley KE
Cancer Res; 1991 Apr; 51(8):2151-7. PubMed ID: 2009533
[TBL] [Abstract][Full Text] [Related]
13. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Moll UM; Youngleib GL; Rosinski KB; Quigley JP
Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
15. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
16. Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium.
Jones BE; Moshyedi P; Gallo S; Tombran-Tink J; Arand G; Reid DA; Thompson EW; Chader GJ; Waldbillig RJ
Exp Eye Res; 1994 Sep; 59(3):257-69. PubMed ID: 7821370
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
Alexander JP; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
[TBL] [Abstract][Full Text] [Related]
18. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.
Oliver GW; Leferson JD; Stetler-Stevenson WG; Kleiner DE
Anal Biochem; 1997 Jan; 244(1):161-6. PubMed ID: 9025922
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
[TBL] [Abstract][Full Text] [Related]
20. Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts.
Brinckerhoff CE; Sirum-Connolly KL; Karmilowicz MJ; Auble DT
Matrix Suppl; 1992; 1():165-75. PubMed ID: 1480018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
